General Information of the Compound
Compound ID
CP0554071
Compound Name
N-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3,4-oxadiazol-2-yl]-4-propan-2-yloxybenzamide
    Show/Hide
Structure
Formula
C20H19N3O5
Molecular Weight
381.388
Canonical SMILES
CC(C)Oc1ccc(cc1)C(=O)Nc1nnc(o1)-c1ccc2OCCOc2c1
    Show/Hide
InChI
InChI=1S/C20H19N3O5/c1-12(2)27-15-6-3-13(4-7-15)18(24)21-20-23-22-19(28-20)14-5-8-16-17(11-14)26-10-9-25-16/h3-8,11-12H,9-10H2,1-2H3,(H,21,23,24)
    Show/Hide
InChIKey
HJSLUYNZQFRSCN-UHFFFAOYSA-N
Physicochemical Property
logP
3.5473
Rotatable Bonds
5
Heavy Atom Count
28
Polar Areas
95.71
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 3329455
ChEMBL ID
CHEMBL4519742
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06356, Adenylate cyclase type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 7500 nM
   TI
   LI
   LO
   TS